655 results on '"Skin Diseases, Infectious epidemiology"'
Search Results
2. Dermatological conditions in the intensive care unit at a tertiary care hospital in Riyadh, Saudi Arabia.
- Author
-
Altammami GS, Alswayed SK, AlJasser MI, and Alkhodair RA
- Subjects
- Humans, Saudi Arabia epidemiology, Male, Female, Adult, Child, Middle Aged, Adolescent, Retrospective Studies, Infant, Aged, Child, Preschool, Young Adult, Aged, 80 and over, Drug Eruptions epidemiology, Drug Eruptions etiology, Skin Diseases, Infectious epidemiology, Vasculitis epidemiology, Hemangioma epidemiology, Herpes Zoster epidemiology, Dermatitis, Contact epidemiology, Dermatitis, Contact etiology, Autoimmune Diseases epidemiology, Infant, Newborn, Candidiasis epidemiology, Thrombocytopenia epidemiology, Skin Diseases epidemiology, Intensive Care Units statistics & numerical data, Tertiary Care Centers
- Abstract
Objectives: To evaluate the various skin conditions diagnosed in intensive care unit (ICU) patients., Methods: This is a descriptive retrospective study of all adults, pediatric, and neonatal patients who were admitted to the ICU and had a dermatological manifestation during hospital stay or patients who had dermatological condition that requires ICU admission. All skin conditions were categorized and analyzed., Results: A total of 344 ICU patients with 365 different dermatological conditions were included in the study. The age of patients ranged from less than 1-96 years, with a mean age of 43.6±30.1 years. Of the patients, 189 (54.9%) were males. The top 3 general disease categories observed were skin infections, inflammatory and autoimmune diseases, and drug reactions. The most commonly reported dermatological disorders included morbilliform drug eruption (6.8%), contact dermatitis (6.3%), vasculitis (5.5%), herpes zoster (4.6%), purpura due to thrombocytopenia (3.8%), dermatitis/eczema (3.8%), candidiasis (3.8%), infantile hemangioma (2.7%), unclassified drug reaction (2.5%), intertrigo (2.5%), and herpes simplex virus (2.5%)., Conclusion: Dermatological disorders can occur at various levels of severity in the ICU. Skin infections, inflammatory and autoimmune diseases, and drug reactions were found to be the most prevalent conditions., (Copyright: © Saudi Medical Journal.)
- Published
- 2024
- Full Text
- View/download PDF
3. Systemic therapy for psoriasis and the risk of cutaneous infections.
- Author
-
Higashi Y, Imafuku S, Tsuruta N, and Murotani K
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Incidence, Japan epidemiology, Aged, Follow-Up Studies, Registries statistics & numerical data, Dermatologic Agents adverse effects, Dermatologic Agents therapeutic use, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious microbiology, Biological Products adverse effects, Biological Products therapeutic use, Psoriasis drug therapy, Psoriasis epidemiology, Psoriasis complications
- Abstract
Systemic treatments are important for patients with moderate-to-severe psoriasis; however, they may occasionally cause adverse infectious events. Although the risk of severe infections with psoriatic treatments is well established, little is known about cutaneous infections. Therefore, we studied the frequency of cutaneous infections in patients with psoriasis who underwent biologic treatment. A total of 878 patients (237 females and 641 males) were analyzed in this follow-up survey conducted in 2020 and based on the Western Japan Psoriasis Registry. The observed skin phenotypes were psoriasis vulgaris (83.3%), pustular psoriasis (7.5%), and psoriatic arthritis (28.9%). The most frequently prescribed systemic drug was apremilast (11.3%), followed by ixekizumab (11.0%), risankizumab (10.9%), and secukinumab (10.4%). The incidence of cutaneous bacterial infections was 12 (1.37% of the total patients), with cellulitis being the most common (8/12, 67%). The incidence of viral infections was 11 (1.25%) including the most common, herpes zoster (9/11, 82%); and that of fungal infections was 45 (5.13%) including 33 (73%) and seven (16%) patients with trichophytosis and oral candidiasis, respectively. Multivariate analysis revealed that cutaneous bacterial infections were frequently observed in patients receiving tumor necrosis factor-α (odds raio [OR] 9.917, 95% confidence interval [CI] 2.069-47.572, p = 0.004) and interleukin (IL)-17 (OR 10.798, 95% CI 2.35-49.616, p = 0.002) inhibitor treatments. A history of otitis media and treatment with oral medications (OR 4.50, 95% CI 1.281-15.804, p = 0.019 and OR 3.80, 95% CI 1.141-12.679, p = 0.03 respectively) were associated with a higher ORs for cutaneous viral infections. Furthermore, age and use of IL-17 inhibitors were associated with elevated ORs for fungal infections. In conclusion, our study reveals that systemic therapies may increase the risk of cutaneous viral infections. Therefore, dermatologists should exercise caution in this regard., (© 2024 The Author(s). The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.)
- Published
- 2024
- Full Text
- View/download PDF
4. Successful treatment of cutaneous protothecosis with fluconazole: A case report and epidemiology study of Prototheca infection in China.
- Author
-
Xu C, Pan C, Xu C, Zheng W, Yin Q, Pan H, and Chen Y
- Subjects
- Humans, Antifungal Agents therapeutic use, China epidemiology, Skin Diseases, Infectious drug therapy, Skin Diseases, Infectious microbiology, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious diagnosis, Fluconazole therapeutic use, Fluconazole administration & dosage, Prototheca isolation & purification
- Abstract
Background: Protothecosis is an infection of humans and animals caused by a rare conditionally pathogenic fungus (prototheca). It can occur in immunocompromised or normal patients., Aims: To describe the epidemiology of prototheca infection in China., Methods: We report a case of successful treatment of cutaneous protothecosis with fluconazole and analyzed the epidemiological characteristics, risk factors, clinical manifestations, diagnosis, treatment and prognosis of prototheca infections in China., Results: We describe this case and 29 cases of prototheca infections in China. At present, Prototheca wickerhamii (Pw) infection is the most common infection in China, and single or combined itraconazole is the preferred treatment., Conclusions: These results provide detailed information and relevant clinical treatment strategies for the diagnosis and treatment of protothecosis in China., (© 2024 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
5. Community-acquired skin and soft-tissue infections in people who inject drugs.
- Author
-
Allaw F, Zakhour J, and Kanj SS
- Subjects
- Humans, Skin, Soft Tissue Infections etiology, Soft Tissue Infections complications, Substance Abuse, Intravenous complications, Substance Abuse, Intravenous epidemiology, Drug Users, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious etiology, Community-Acquired Infections etiology, Community-Acquired Infections complications, Methicillin-Resistant Staphylococcus aureus
- Abstract
Purpose of Review: The aim of this review is to discuss the latest evidence of the epidemiology, microbiology, risk factors, diagnosis and management of community-acquired skin and soft tissue infections (SSTIs) in people who inject drug (PWID)., Recent Findings: SSTIs are common complications in PWID and a major cause of morbidity and mortality. Infections can range from uncomplicated cellulitis, to abscesses, deep tissue necrosis and necrotizing fasciitis. They are predominantly caused by Gram-positive pathogens in particular Staphylococcus aureus and Streptococcus species; however, toxin-producing organisms such as Clostridium botulism or Clostridium tetani should be considered. The pathogenesis of SSTI in the setting of intravenous drug use (IDU) is different from non-IDU related SSTI, and management often requires surgical interventions in addition to adjunctive antibiotics. Harm reduction strategies and education about safe practices should be implemented to prevent morbidity and mortality as well as healthcare burden of SSTI in PWID., Summary: Prompt diagnosis and proper medical and surgical management of SSTI will improve outcomes in PWID., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Increased incidence of cutaneous Staphylococcusaureus infections after the 2010 floods in the Var department of France: Rumour or reality?
- Author
-
Suarez-Diaz E, Hubiche T, and Del Giudice P
- Subjects
- Floods, France epidemiology, Humans, Incidence, Prospective Studies, Staphylococcus aureus, Dermatitis, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious etiology, Staphylococcal Infections
- Abstract
Background: Natural disasters are typically associated with the emergence of infectious diseases. On 15 June 2010, severe storms caused flooding in the Var department (France). A rumour about increased risk of Staphylococcusaureus skin infections after bathing in the sea began to circulate on Internet a few days after the floods. The aim of this study was to compare the rumour with the true incidence of cases of infection., Methods: Since 1999, we have been conducting a prospective survey of S. aureus skin infections in our hospital to study their clinical, laboratory and epidemiologic features. We compared data on cases of Staphylococcus skin infection recorded in our institution from 2008 to 2012., Results: We found that there was no increase in S. aureus skin infections after the floods compared to the previous and subsequent years., Conclusion: We had a unique opportunity to check the rumoured increase in incidence of infectious disease with the true incidence. In our study, the fear of S. aureus skin infections following flooding proved to be unfounded., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
7. Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 3: infectious skin diseases.
- Author
-
Hansen I, Augustin M, Schäfer I, and Mohr N
- Subjects
- Germany epidemiology, Humans, Skin pathology, Measles, Noncommunicable Diseases, Skin Diseases, Infectious epidemiology, Skin Neoplasms pathology
- Abstract
The aim of this work was to systematically collect all previously published population-based epidemiological data on skin diseases in Germany. A systematic literature search was performed using PubMed/MEDLINE for the period of the last 15 years. With the aim to include all dermatological diseases, a diagnostic list based on the ICD-11 catalogue was compiled. This list included 1,347 skin diseases and formed the basis for the search. The present part 3 of the publication series deals with infectious skin diseases. The results on cutaneous tumor diseases (part 1) and non-infectious skin diseases (part 2) form the other parts of this publication series. The literature search yielded 4,605 hits, of which 72 papers on 43 different skin diseases were included in the synthesis. Among them were twelve hits on infectious dermatoses, of which six papers were related to measles. The highest lifetime prevalence rates were found for varicella and verrucae vulgaris. This work is the first systematic literature review that aimed to report all available epidemiological data on skin diseases in Germany. It was found that representative data on many infectious diseases are not yet available. Among the included studies, a high heterogeneity was found with regard to the methodology. Nevertheless, these epidemiological data have a wide range of uses and can serve as a reference for various epidemiological questions., (© 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
- Published
- 2022
- Full Text
- View/download PDF
8. Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 2: non-infectious skin diseases.
- Author
-
Hansen I, Augustin M, Schäfer I, and Mohr N
- Subjects
- Humans, Skin, Noncommunicable Diseases, Psoriasis epidemiology, Skin Diseases diagnosis, Skin Diseases epidemiology, Skin Diseases, Infectious epidemiology, Skin Neoplasms diagnosis, Skin Neoplasms epidemiology
- Abstract
The aim of this work was to systematically collect all previously published population-based epidemiological data on skin diseases in Germany. The present part 2 of the publication series deals with non-infectious skin diseases. The results on cutaneous tumor diseases (part 1) and infectious skin diseases (part 3) form the other parts of this publication series. A systematic literature search was performed using PubMed/MEDLINE for the period of the last 15 years. With the aim of including all dermatologic diseases, a diagnostic list was developed based on the ICD-11 catalogue. This list included 1,347 skin diseases and formed the basis for the search. The literature search yielded 4,650 hits, of which 72 were included in the synthesis. Among them were 37 publications on non-infectious skin diseases. Among these, psoriasis and atopic eczema were the most common. The highest lifetime prevalence was found for acne. This work is the first systematic literature review that aimed to report all available epidemiological data on skin diseases in Germany. It was found that representative data on many non-infectious diseases are not yet available. Among the included studies, there was a high heterogeneity regarding the methodology. Nevertheless, the utility of these epidemiological data is wide-ranging and can serve as a reference of various epidemiological questions., (© 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
- Published
- 2022
- Full Text
- View/download PDF
9. Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs.
- Author
-
Freibott CE, Phillips KT, Anderson BJ, Stewart C, Liebschutz JM, and Stein MD
- Subjects
- Female, Humans, Injections, Subcutaneous, Male, Pharmaceutical Preparations, Drug Users, Skin Diseases, Infectious epidemiology, Substance Abuse, Intravenous complications, Substance Abuse, Intravenous epidemiology
- Abstract
Objectives: People who inject drugs (PWID) are at increased risk for numerous negative health outcomes. Subcutaneous injections (aka skin popping) can result in greater risk of skin and soft tissue infections (SSTIs), but less is known about PWID who choose this route of administration. This study compares subcutaneous injectors to intravenous injectors, characterizes those who inject subcutaneously, and examines whether subcutaneous injection is associated with SSTIs in the past year., Methods: A cohort of hospitalized PWID (n = 252) were interviewed regarding injection-related behaviors, history of SSTI, and knowledge of subcutaneous injection risk. We examined differences between those who do and do not inject subcutaneously and used a negative binomial regression model to estimate adjusted odds associating subcutaneous injection and SSTI., Results: Participants averaged 38 years, with 58.3% male, 59.5% White, 20.6% Black, and 15.9% Latinx. PWID who performed subcutaneous injection were not demographically different from other PWID; however, the mean rate of past year SSTIs was higher for persons injecting subcutaneously than for those who did not (1.98 vs 0.96, P < 0.001). Persons injecting subcutaneously did not differ from those who injected intravenously in terms of their knowledge of subcutaneous injection risk (P = 0.112) and knowledge score was not associated with SSTIs (P = 0.457)., Conclusions: PWID who perform subcutaneous injections are demographically similar to other PWID but had higher rates of past year SSTIs. Knowledge of subcutaneous injection risk was not associated with SSTI risk., Competing Interests: Dr. Stein received $7000 from Alkermes, Inc to review grants for the Young Investigator Research Program. The remaining authors report no conflicts of interest., (Copyright © 2021 American Society of Addiction Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
10. Sequence type 8 as an emerging clone of methicillin-resistant Staphylococcus aureus causing bloodstream infections in Taiwan.
- Author
-
Chen PY, Chuang YC, Wang JT, Sheng WH, Chen YC, and Chang SC
- Subjects
- Aged, Aged, 80 and over, Bacteremia drug therapy, Bacteremia microbiology, DNA, Bacterial genetics, Female, Humans, Male, Methicillin-Resistant Staphylococcus aureus classification, Methicillin-Resistant Staphylococcus aureus genetics, Middle Aged, Retrospective Studies, Skin Diseases, Infectious microbiology, Soft Tissue Infections microbiology, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Taiwan epidemiology, Anti-Bacterial Agents pharmacology, Bacteremia epidemiology, Methicillin-Resistant Staphylococcus aureus drug effects, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Staphylococcal Infections epidemiology
- Abstract
Sequence type (ST) 8 has not been a common methicillin-resistant Staphylococcus aureus (MRSA) clone in Asia until recently. We aimed to determine the clinical significance and microbiological characteristics of MRSA bacteraemia (MRSAB) caused by ST8 and other endemic clones. A total of 281 non-duplicated MRSAB were identified in a medical centre between 2016 and 2018. Sequencing of target genes was performed to determine ST and to confirm ST8 belonging to USA300. Antimicrobial susceptibility testing was performing by using Sensititre standard panel. In total, ST8 accounted for 18.5% of MRSAB ranking after ST239 (31.0%) and ST59 (23.5%). However, it increased to become the most prevalent clone finally. All ST8 isolates belonged to spa clonal complex008, and carried SCC mec IV/IVa, PVL and ACME genes, indicating USA300. ST8/USA300 isolates were highly susceptible to non-β-lactams antibiotics, except fluoroquinolone and erythromycin. ST8/USA300 MRSAB is commonly developed in community settings with either healthcare risks or not (71.2%). Compared to other STs MRSAB, ST8/USA300 MRSAB patients had more diabetes mellitus (50.0%), more admitted from long-term care facility residents (25.0%), had more skin ad soft tissue infection as primary focus (25.0%), and had fewer vascular devices (26.9%) at MRSAB onset. On multivariable analysis, isolates with vancomycin MIC were significantly associated with mortality in the dose-response relationship, rather than STs. This report depicts the clinical features of ST8/USA300 MRSAB and clonal shift from prior endemic clones to ST8/USA300. Our data strongly support long-term surveillance to ascertain whether ST8/USA300 will successfully disseminate and demonstrate its pathogenicity on clinical outcomes.
- Published
- 2021
- Full Text
- View/download PDF
11. Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management.
- Author
-
Sanchez DP, Tookes H, Pastar I, and Lev-Tov H
- Subjects
- Drug Users, Humans, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Substance Abuse, Intravenous epidemiology, United States epidemiology, Bacterial Infections epidemiology, Skin Diseases, Infectious microbiology, Soft Tissue Infections microbiology, Substance Abuse, Intravenous complications, Syringes microbiology
- Abstract
Significance: Opioid use disorder and transition to injection drug use (IDU) are an urgent, nationwide public health crisis. Wounds and skin and soft tissue infections (SSTIs) are common complications of IDU that disproportionately affect people who inject drugs (PWID) and are a major source of morbidity and mortality for this population. Critical Issues: Injections in a nonsterile environment and reusing or sharing needles facilitates bacterial inoculation, with subsequent risk of serious complications such as sepsis, gangrene, amputation, and death. PWID are susceptible to infections with a wide spectrum of organisms beyond common culprits of SSTI, including Clostridium and Bacillus spp., as well as Candida . Recent Advances: Syringe services programs (SSPs) are cost-effective and successful in reducing harms associated with IDU. SSPs provide new equipment to PWID and aid in discarding used equipment. SSPs aim to reduce the risks of unhygienic injecting practices, which are associated with transmission of infections and blood-borne pathogens. Future Directions: Concurrently run SSPs and wound care clinics are uniquely positioned to facilitate care to PWID. Providing new, sterile equipment as well as early wound care intervention can reduce morbidity and mortality as well as health care expenditures by reducing the number of SSTI and injection-related wounds that require hospital admission. Establishment of wound care clinics as part of an SSP represents an untapped potential to reduce harm.
- Published
- 2021
- Full Text
- View/download PDF
12. Correlates of injection-related wounds and skin infections amongst persons who inject drugs and use a syringe service programme: A single center study.
- Author
-
Cahn BA, Bartholomew TS, Patel HP, Pastar I, Tookes HE, and Lev-Tov H
- Subjects
- Adult, Female, Humans, Syringes, Drug Users, HIV Infections, Pharmaceutical Preparations, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious etiology, Substance Abuse, Intravenous epidemiology
- Abstract
Risk factors associated with wounds and skin infections amongst persons who inject drugs may have changed in the era of fentanyl and now stimulant coinjection. We assessed the number of injection site wounds and skin infections and associated factors amongst 675 persons who inject drugs in a syringe services programme. Of this sample, 173 participants reported a total of 307 wounds and skin infections. Significant factors associated with increased number of wounds and skin infections were age 30 or older, female gender, ever experiencing homelessness, cocaine injection, and injecting between 5 and 10 years. Wounds and skin infections were common amongst syringe services programme clients and are associated with certain risk factors that may help to design effective interventions. Given the high prevalence of wounds in syringe services programme clients, wound care clinicians can make a significant difference and improve outcomes. We also shed light on correlates of wounds and skin infections in persons who inject drugs in order to spur further research to devise efficacious interventions for this underserved group., (© 2021 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
13. GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections.
- Author
-
Rogne T, Liyanarachi KV, Rasheed H, Thomas LF, Flatby HM, Stenvik J, Løset M, Gill D, Burgess S, Willer CJ, Hveem K, Åsvold BO, Brumpton BM, DeWan AT, Solligård E, and Damås JK
- Subjects
- Adult, Aged, Female, Genetic Loci, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Linkage Disequilibrium, Male, Middle Aged, Risk Factors, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, RNA, Long Noncoding genetics, Skin Diseases, Infectious genetics, Soft Tissue Infections genetics, Solute Carrier Family 12, Member 2 genetics
- Published
- 2021
- Full Text
- View/download PDF
14. Delayed diagnosis of nonendemic dermatologic diseases: A retrospective review.
- Author
-
Thomas C and Nambudiri VE
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Retrospective Studies, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious microbiology, Skin Diseases, Infectious parasitology, Time Factors, United States epidemiology, Young Adult, Delayed Diagnosis statistics & numerical data, Skin Diseases, Infectious epidemiology, Travel-Related Illness
- Published
- 2021
- Full Text
- View/download PDF
15. Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.
- Author
-
Pai MP
- Subjects
- Body Surface Area, Body Weight, Dose-Response Relationship, Drug, Humans, Metabolic Clearance Rate, Phenotype, Skin Diseases, Infectious drug therapy, Skin Diseases, Infectious epidemiology, Anti-Bacterial Agents administration & dosage, Drug Dosage Calculations, Obesity epidemiology
- Abstract
Obesity and its related comorbidities can negatively influence the outcomes of certain infectious diseases. Specific dosing recommendations are often lacking in the product label for patients with obesity that leads to unclear guidance in practice. Higher rates of therapeutic failure have been reported with some fixed dose antibiotics and pragmatic approaches to dose modification are limited for orally administered agents. For i.v. antimicrobials dosed on weight, alternate body size descriptors (ABSDs) have been used to reduce the risk of overdosing. These ABSDs are mathematical transformations of height and weight that represent fat-free weight and follow the same principles as body surface area (BSA)-based dosing of cancer chemotherapy. However, ABSDs are rarely studied in pivotal phase III studies and so can risk the underdosing of antimicrobials in patients with obesity when incorrectly applied in the real-world setting. Specific case examples are presented to highlight these risks. Although general principles may be considered by clinicians, a universal approach to dose modification in obesity is unlikely. Studies that can better distinguish human body phenotypes may help reduce our reliance on height and weight to define dosing. Simple and complex technologies exist to quantify individual body composition that could improve upon our current approach. Early evidence suggests that body composition parameters repurposed from medical imaging data may improve upon height and weight as covariates of drug clearance and distribution. Clinical trials that can integrate human body phenotyping may help us identify new approaches to optimal dose selection of antimicrobials in patients with obesity., (© 2021 The Authors. Clinical Pharmacology & Therapeutics © 2021 American Society for Clinical Pharmacology and Therapeutics.)
- Published
- 2021
- Full Text
- View/download PDF
16. Allergic contact dermatitis and other occupational skin diseases in health care workers in the Finnish Register of Occupational Diseases in 2005-2016.
- Author
-
Aalto-Korte K, Koskela K, and Pesonen M
- Subjects
- Dermatitis, Allergic Contact etiology, Dermatitis, Irritant epidemiology, Dermatitis, Irritant etiology, Dermatitis, Occupational etiology, Finland epidemiology, Humans, Incidence, Registries, Skin Diseases, Infectious epidemiology, Dermatitis, Allergic Contact epidemiology, Dermatitis, Occupational epidemiology, Health Personnel statistics & numerical data
- Abstract
Background: Health care workers are an important risk group for occupational skin disease (OSD)., Aims: To study diagnoses and causes of OSDs in health care workers in the Finnish Register of Occupational Diseases (FROD) in 2005-2016., Methods: We searched the FROD for dermatological cases (a) in health care-related occupations defined by ISCO-08 and (b) in the industrial branch of health care defined by European industry standard classification system (NACE rev. 2)., Results: Health care workers comprised 19% of all OSD cases in the FROD, and irritant contact dermatitis dominated the diagnoses. Nurses and assistant nurses were the largest occupational groups with incidence rates of 3.3 and 2.7/10 000 person years, respectively. Rubber chemicals were by far the most common causative agents of allergic contact dermatitis (ACD) followed by preservatives, the latter mainly comprising isothiazolinones and formaldehyde. Acrylates were important allergens in dental professions. Metals and coconut fatty acid derivatives were the next largest causative groups for ACD. Drugs caused only 1% of the ACD cases., Conclusions: Workers in different health care occupations do not have a uniform risk for OSD, but they share the risk for ACD due to rubber chemicals and various preservatives., (© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
17. Skin and Soft Tissue Infections in Patients with Diabetes Mellitus.
- Author
-
Polk C, Sampson MM, Roshdy D, and Davidson LE
- Subjects
- Anti-Bacterial Agents therapeutic use, Debridement methods, Diabetes Mellitus therapy, Diabetic Foot epidemiology, Diabetic Foot therapy, Drug Resistance, Bacterial, Gangrene epidemiology, Humans, Osteomyelitis epidemiology, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious therapy, Soft Tissue Infections diagnosis, Soft Tissue Infections therapy, Diabetes Mellitus epidemiology, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology
- Abstract
Skin and soft tissue infections are common in diabetics. Diabetic foot infection usually results from disruption of the skin barrier, trauma, pressure, or ischemic wounds. These wounds may become secondarily infected or lead to development of adjacent soft tissue or deeper bone infection. Clinical assessment and diagnosis of these conditions using a multidisciplinary management approach, including careful attention to antibiotic selection, lead to the best outcomes in patient care., Competing Interests: Disclosure C. Polk has received research funding from Merck, United States., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta-analysis.
- Author
-
Kelleher MM, Cro S, Van Vogt E, Cornelius V, Lodrup Carlsen KC, Ove Skjerven H, Rehbinder EM, Lowe A, Dissanayake E, Shimojo N, Yonezawa K, Ohya Y, Yamamoto-Hanada K, Morita K, Cork M, Cooke A, Simpson EL, McClanahan D, Weidinger S, Schmitt J, Axon E, Tran L, Surber C, Askie LM, Duley L, Chalmers JR, Williams HC, and Boyle RJ
- Subjects
- Humans, Infant, Infant, Newborn, Skin Care, Skin Diseases, Infectious epidemiology, Soaps, Water Softening, Dermatitis, Atopic prevention & control, Emollients therapeutic use, Food Hypersensitivity prevention & control
- Abstract
Objective: Eczema and food allergy start in infancy and have shared genetic risk factors that affect skin barrier. We aimed to evaluate whether skincare interventions can prevent eczema or food allergy., Design: A prospectively planned individual participant data meta-analysis was carried out within a Cochrane systematic review to determine whether skincare interventions in term infants prevent eczema or food allergy., Data Sources: Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and trial registries to July 2020., Eligibility Criteria for Selected Studies: Included studies were randomized controlled trials of infants <1 year with healthy skin comparing a skin intervention with a control, for prevention of eczema and food allergy outcomes between 1 and 3 years., Results: Of the 33 identified trials, 17 trials (5823 participants) had relevant outcome data and 10 (5154 participants) contributed to IPD meta-analysis. Three of seven trials contributing to primary eczema analysis were at low risk of bias, and the single trial contributing to primary food allergy analysis was at high risk of bias. Interventions were mainly emollients, applied for the first 3-12 months. Skincare interventions probably do not change risk of eczema by age 1-3 years (RR 1.03, 95% CI 0.81, 1.31; I
2 =41%; moderate certainty; 3075 participants, 7 trials). Sensitivity analysis found heterogeneity was explained by increased eczema in a trial of daily bathing as part of the intervention. It is unclear whether skincare interventions increase risk of food allergy by age 1-3 years (RR 2.53, 95% CI 0.99 to 6.47; very low certainty; 996 participants, 1 trial), but they probably increase risk of local skin infections (RR 1.34, 95% CI 1.02, 1.77; I2 =0%; moderate certainty; 2728 participants, 6 trials)., Conclusion: Regular emollients during infancy probably do not prevent eczema and probably increase local skin infections., (© 2021 John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
19. Skin and Soft Tissue Infections in Persons Who Inject Drugs.
- Author
-
Chambers HF
- Subjects
- Abscess epidemiology, Anti-Bacterial Agents therapeutic use, Cellulitis epidemiology, Clostridium perfringens isolation & purification, Clostridium sordellii isolation & purification, Debridement methods, Drainage methods, Drug Users, Fasciitis, Necrotizing epidemiology, Gram-Positive Bacterial Infections epidemiology, Humans, Pyomyositis epidemiology, Skin Diseases, Infectious microbiology, Skin Diseases, Infectious therapy, Soft Tissue Infections microbiology, Soft Tissue Infections therapy, Staphylococcus aureus isolation & purification, Streptococcus pyogenes isolation & purification, Substance Abuse, Intravenous microbiology, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Substance Abuse, Intravenous epidemiology
- Abstract
Persons who inject drugs are at high risk for skin and soft tissue infections. Infections range from simple abscesses and uncomplicated cellulitis to life-threatening and limb-threatening infections. These infections are predominantly caused by gram-positive organisms with Staphylococcus aureus, Streptococcus pyogenes, and other streptococcal species being most common. Although antimicrobial therapy has an important role in treatment of these infections, surgical incision, drainage, and debridement of devitalized tissue are primary. Strategies that decrease the frequency of injection drug use, needle sharing, use of contaminated equipment, and other risk behaviors may be effective in preventing these infections in persons who inject drugs., Competing Interests: Disclosure The author has nothing to disclose., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. Longitudinal whole-genome based comparison of carriage and infection associated Staphylococcus aureus in northern Australian dialysis clinics.
- Author
-
Holt DC, Harris TM, Hughes JT, Lilliebridge R, Croker D, Graham S, Hall H, Wilson J, Tong SYC, and Giffard PM
- Subjects
- Adult, Australia epidemiology, Bacterial Proteins genetics, Bacterial Toxins genetics, Carrier State microbiology, Exotoxins genetics, Humans, Leukocidins genetics, Longitudinal Studies, Multilocus Sequence Typing methods, Penicillin-Binding Proteins genetics, Polymorphism, Single Nucleotide, Prospective Studies, Skin Diseases, Infectious microbiology, Staphylococcal Infections microbiology, Whole Genome Sequencing methods, Carrier State epidemiology, Carrier State transmission, Genes, Bacterial, Renal Dialysis, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious transmission, Staphylococcal Infections epidemiology, Staphylococcal Infections transmission, Staphylococcus aureus genetics
- Abstract
Background: The study objective was to reveal reservoirs potentially leading to Staphylococcus aureus infections in haemodialysis clinic clients in the tropical north of the Australian Northern Territory (NT). This client population are primarily Aboriginal Australians who have a greater burden of ill health than other Australians. Reservoir identification will enhance infection control in this client group, including informing potential S. aureus decolonisation strategies., Methods and Findings: The study participants were 83 clients of four haemodialysis clinics in the Darwin region of the NT, and 46 clinical staff and researchers who had contact with the clinic clients. The study design was longitudinal, encompassing swabbing of anatomical sites at two month intervals to yield carriage isolates, and also progressive collection of infection isolates. Swab sampling was performed for all participants, and infection isolates collected for dialysis clients only. Analysis was based on the comparison of 139 carriage isolates and 27 infection isolates using whole genome sequencing. Genome comparisons were based on of 20,651 genome-wide orthologous SNPs, presence/absence of the mecA and pvl genes, and inferred multilocus sequence type and clonal complex. Pairs of genomes meeting the definition of "not discriminated" were classed as defining potential transmission events. The primary outcome was instances of potential transmission between a carriage site other than a skin lesion and an infection site, in the same individual. Three such instances were identified. Two involved ST762 (CC1) PVL- MRSA, and one instance ST121 PVL+ MSSA. Three additional instances were identified where the carriage strains were derived from skin lesions. Also identified were six instances of potential transmission of a carriage strains between participants, including transmission of strains between dialysis clients and staff/researchers, and one potential transmission of a clinical strain between participants. There were frequent occurrences of longitudinal persistence of carriage strains in individual participants, and two examples of the same strain causing infection in the same participants at different times. Strains associated with infections and skin lesions were enriched for PVL and mecA in comparison to strains associated with long term carriage., Conclusions: This study indicated that strains differ with respect to propensity to stably colonise sites such as the nose, and cause skin infections. PVL+ strains were associated with infection and skin lesions and were almost absent from the carriage sites. PVL- MRSA (mainly CC1) strains were associated with infection and also with potential transmission events involving carriage sites, while PVL- MSSA were frequently observed to stably colonise individuals without causing infection, and to be rarely transmitted. Current clinical guidelines for dialysis patients suggest MRSA decolonisation. Implementation in this client group may impact infections by PVL- MRSA, but may have little effect on infection by PVL+ strains. In this study, the PVL+ strains were predominant causes of infection but rarely colonised typical carriage sites such as the nose, and in the case of ST121, were MSSA. The important reservoirs for infection by PVL+ strains appeared to be prior infections., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
21. Skin care interventions in infants for preventing eczema and food allergy.
- Author
-
Kelleher MM, Cro S, Cornelius V, Lodrup Carlsen KC, Skjerven HO, Rehbinder EM, Lowe AJ, Dissanayake E, Shimojo N, Yonezawa K, Ohya Y, Yamamoto-Hanada K, Morita K, Axon E, Surber C, Cork M, Cooke A, Tran L, Van Vogt E, Schmitt J, Weidinger S, McClanahan D, Simpson E, Duley L, Askie LM, Chalmers JR, Williams HC, and Boyle RJ
- Subjects
- Bias, Female, Filaggrin Proteins, Food Hypersensitivity immunology, Humans, Hypersensitivity, Immediate immunology, Immunoglobulin E immunology, Infant, Infant, Newborn, Male, Milk Hypersensitivity etiology, Skin Diseases, Infectious epidemiology, Soaps, Eczema prevention & control, Emollients therapeutic use, Food Hypersensitivity prevention & control, Skin Care methods
- Abstract
Background: Eczema and food allergy are common health conditions that usually begin in early childhood and often occur together in the same people. They can be associated with an impaired skin barrier in early infancy. It is unclear whether trying to prevent or reverse an impaired skin barrier soon after birth is effective in preventing eczema or food allergy., Objectives: Primary objective To assess effects of skin care interventions, such as emollients, for primary prevention of eczema and food allergy in infants Secondary objective To identify features of study populations such as age, hereditary risk, and adherence to interventions that are associated with the greatest treatment benefit or harm for both eczema and food allergy., Search Methods: We searched the following databases up to July 2020: Cochrane Skin Specialised Register, CENTRAL, MEDLINE, and Embase. We searched two trials registers and checked reference lists of included studies and relevant systematic reviews for further references to relevant randomised controlled trials (RCTs). We contacted field experts to identify planned trials and to seek information about unpublished or incomplete trials., Selection Criteria: RCTs of skin care interventions that could potentially enhance skin barrier function, reduce dryness, or reduce subclinical inflammation in healthy term (> 37 weeks) infants (0 to 12 months) without pre-existing diagnosis of eczema, food allergy, or other skin condition were included. Comparison was standard care in the locality or no treatment. Types of skin care interventions included moisturisers/emollients; bathing products; advice regarding reducing soap exposure and bathing frequency; and use of water softeners. No minimum follow-up was required., Data Collection and Analysis: This is a prospective individual participant data (IPD) meta-analysis. We used standard Cochrane methodological procedures, and primary analyses used the IPD dataset. Primary outcomes were cumulative incidence of eczema and cumulative incidence of immunoglobulin (Ig)E-mediated food allergy by one to three years, both measured by the closest available time point to two years. Secondary outcomes included adverse events during the intervention period; eczema severity (clinician-assessed); parent report of eczema severity; time to onset of eczema; parent report of immediate food allergy; and allergic sensitisation to food or inhalant allergen., Main Results: This review identified 33 RCTs, comprising 25,827 participants. A total of 17 studies, randomising 5823 participants, reported information on one or more outcomes specified in this review. Eleven studies randomising 5217 participants, with 10 of these studies providing IPD, were included in one or more meta-analysis (range 2 to 9 studies per individual meta-analysis). Most studies were conducted at children's hospitals. All interventions were compared against no skin care intervention or local standard care. Of the 17 studies that reported our outcomes, 13 assessed emollients. Twenty-five studies, including all those contributing data to meta-analyses, randomised newborns up to age three weeks to receive a skin care intervention or standard infant skin care. Eight of the 11 studies contributing to meta-analyses recruited infants at high risk of developing eczema or food allergy, although definition of high risk varied between studies. Durations of intervention and follow-up ranged from 24 hours to two years. We assessed most of this review's evidence as low certainty or had some concerns of risk of bias. A rating of some concerns was most often due to lack of blinding of outcome assessors or significant missing data, which could have impacted outcome measurement but was judged unlikely to have done so. Evidence for the primary food allergy outcome was rated as high risk of bias due to inclusion of only one trial where findings varied when different assumptions were made about missing data. Skin care interventions during infancy probably do not change risk of eczema by one to two years of age (risk ratio (RR) 1.03, 95% confidence interval (CI) 0.81 to 1.31; moderate-certainty evidence; 3075 participants, 7 trials) nor time to onset of eczema (hazard ratio 0.86, 95% CI 0.65 to 1.14; moderate-certainty evidence; 3349 participants, 9 trials). It is unclear whether skin care interventions during infancy change risk of IgE-mediated food allergy by one to two years of age (RR 2.53, 95% CI 0.99 to 6.47; 996 participants, 1 trial) or allergic sensitisation to a food allergen at age one to two years (RR 0.86, 95% CI 0.28 to 2.69; 1055 participants, 2 trials) due to very low-certainty evidence for these outcomes. Skin care interventions during infancy may slightly increase risk of parent report of immediate reaction to a common food allergen at two years (RR 1.27, 95% CI 1.00 to 1.61; low-certainty evidence; 1171 participants, 1 trial). However, this was only seen for cow's milk, and may be unreliable due to significant over-reporting of cow's milk allergy in infants. Skin care interventions during infancy probably increase risk of skin infection over the intervention period (RR 1.34, 95% CI 1.02 to 1.77; moderate-certainty evidence; 2728 participants, 6 trials) and may increase risk of infant slippage over the intervention period (RR 1.42, 95% CI 0.67 to 2.99; low-certainty evidence; 2538 participants, 4 trials) or stinging/allergic reactions to moisturisers (RR 2.24, 95% 0.67 to 7.43; low-certainty evidence; 343 participants, 4 trials), although confidence intervals for slippages and stinging/allergic reactions are wide and include the possibility of no effect or reduced risk. Preplanned subgroup analyses show that effects of interventions were not influenced by age, duration of intervention, hereditary risk, FLG mutation, or classification of intervention type for risk of developing eczema. We could not evaluate these effects on risk of food allergy. Evidence was insufficient to show whether adherence to interventions influenced the relationship between skin care interventions and risk of developing eczema or food allergy., Authors' Conclusions: Skin care interventions such as emollients during the first year of life in healthy infants are probably not effective for preventing eczema, and probably increase risk of skin infection. Effects of skin care interventions on risk of food allergy are uncertain. Further work is needed to understand whether different approaches to infant skin care might promote or prevent eczema and to evaluate effects on food allergy based on robust outcome assessments., (Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
22. The economic and health burdens of diseases caused by group A Streptococcus in New Zealand.
- Author
-
Cannon JW, Zhung J, Bennett J, Moreland NJ, Baker MG, Geelhoed E, Fraser J, Carapetis JR, and Jack S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cellulitis diagnosis, Cellulitis economics, Cellulitis microbiology, Child, Child, Preschool, Female, Hospitalization economics, Humans, Incidence, Infant, Male, Middle Aged, New Zealand epidemiology, Quality-Adjusted Life Years, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious economics, Skin Diseases, Infectious microbiology, Streptococcal Infections diagnosis, Streptococcal Infections economics, Streptococcal Infections microbiology, Young Adult, Cellulitis epidemiology, Skin Diseases, Infectious epidemiology, Streptococcal Infections epidemiology, Streptococcus pyogenes immunology
- Abstract
Objectives: In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand (NZ)., Methods: The annual incidence of GAS diseases was based on extrapolation of the average number of primary healthcare episodes managed each year in general practices (2014-2016) and on the average number of hospitalizations occurring each year (2005-2014). Disease incidence was multiplied by the average cost of diagnosing and managing an episode of disease at each level of care to estimate the annual economic burden., Results: GAS affected 1.5% of the population each year, resulting in an economic burden of 29.2 million NZ dollars (2015 prices) and inflicting a health burden of 2373 disability-adjusted life years (DALYs). Children <5 years of age were the most likely age group to present for GAS-related healthcare. Presentations for superficial throat and skin infections (predominantly pharyngitis and impetigo) were more common than other GAS diseases. Cellulitis contributed the most to the total economic and health burdens. Invasive and immune-mediated diseases disproportionately contributed to the total economic and health burdens relative to their frequency of occurrence., Conclusion: Preventing GAS diseases would have substantial economic and health benefits in NZ and globally., (Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Toe Web Infection: Epidemiology and Risk Factors in a Large Cohort Study.
- Author
-
Solomon M, Greenbaum H, Shemer A, Barzilai A, and Baum S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Cohort Studies, Female, Foot Dermatoses complications, Foot Dermatoses microbiology, Humans, Incidence, Israel, Male, Middle Aged, Prevalence, Risk Factors, Shoes, Skin Diseases, Infectious complications, Skin Diseases, Infectious microbiology, Smoking, Toes, Young Adult, Foot Dermatoses epidemiology, Skin Diseases, Infectious epidemiology
- Abstract
Introduction: Toe web infection (TWI) is a bacterial infection of the interdigital space. In most cases, the infection is caused by gram-negative bacteria, secondary to a chronic fungal infection (dermatophytosis). The typical presentation includes macerations and erosions in the interdigital space. Predisposing factors include interdigital tinea, hyperhidrosis, and humidity., Objective: The aim of this study was to characterize the TWI patient population and identify associated risk factors., Methods: We conducted a retrospective study of patients diagnosed with TWI from 2006 to 2020 at Sheba Medical Center, Israel. Collected data included patients' demographics (age, sex, weight, and occupation), smoking pack-years, comorbidities, medications, and course of disease., Results: A total of 200 patients were diagnosed with TWI. The median age at diagnosis was 51 years. The majority of the patients were men (72.5%). The most common comorbidities were dyslipidemia, hypertension, diabetes, and ischemic heart disease. We found that 71.2% of patients were smokers, and 46.4% of patients had occupations that required closed-toe shoes. TWI incidence did not increase seasonally. Bilateral TWI was found in 50% of the patients, 33% had recurrent infections, and 20% had secondary cellulitis., Conclusions: Smoking and diabetes were more prevalent among TWI patients than in the general population, and there was a correlation between smoking and TWI recurrences. We identified risk factors for TWI to identify at-risk populations., (© 2020 S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
24. Patterns of Skin Disease in the Context of a High Prevalence HIV Population in Botswana.
- Author
-
Mosojane KI, Giovanni D, Forrestel AK, Conic RZ, Kovarik C, and Williams VL
- Subjects
- Adolescent, Adult, Aged, Biopsy statistics & numerical data, Botswana epidemiology, Child, Child, Preschool, Dermatitis diagnosis, Dermatitis therapy, Dermatitis, Atopic diagnosis, Dermatitis, Atopic epidemiology, Dermatitis, Atopic therapy, Female, Humans, Infant, Lupus Erythematosus, Discoid diagnosis, Lupus Erythematosus, Discoid epidemiology, Lupus Erythematosus, Discoid therapy, Male, Middle Aged, Neurodermatitis diagnosis, Neurodermatitis epidemiology, Neurodermatitis therapy, Prevalence, Retrospective Studies, Sarcoma, Kaposi diagnosis, Sarcoma, Kaposi epidemiology, Sarcoma, Kaposi therapy, Skin Diseases diagnosis, Skin Diseases epidemiology, Skin Diseases therapy, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious therapy, Skin Diseases, Vascular diagnosis, Skin Diseases, Vascular therapy, Skin Neoplasms diagnosis, Skin Neoplasms therapy, Tertiary Care Centers, Warts diagnosis, Warts epidemiology, Warts therapy, Young Adult, Dermatitis epidemiology, HIV Infections epidemiology, Skin Diseases, Infectious epidemiology, Skin Diseases, Vascular epidemiology, Skin Neoplasms epidemiology
- Abstract
The authors reviewed outpatients in a tertiary dermatology clinic in Botswana to expand knowledge on patterns of skin disease in this population with a high prevalence of human immunodeficiency virus (HIV). Approximately one-third of new and follow-up patients were HIV positive. Common dermatologic conditions included eczematous eruptions, viral and fungal infections, malignant neoplasms, vascular disorders, disorders of pigmentation, and mechanical/physical injury-related disorders. HIV has impacted patterns of dermatologic disease in Botswana, with Kaposi sarcoma being the most frequently biopsied condition. Given the shortage of dermatology specialists, resources should be allocated toward education and management of these most prevalent skin conditions., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Molecular characterization of Prototheca in 11 symptomatic dogs.
- Author
-
Falcaro C, Furlanello T, Binanti D, Fondati A, Bonfanti U, Krockenberger M, Malik R, and Danesi P
- Subjects
- Animals, Dogs, Feces, Italy epidemiology, Pilot Projects, Prototheca classification, Prototheca genetics, RNA, Algal analysis, RNA, Ribosomal, 28S analysis, Real-Time Polymerase Chain Reaction veterinary, Skin Diseases, Infectious epidemiology, Dog Diseases epidemiology, Prototheca isolation & purification, Skin Diseases, Infectious veterinary
- Abstract
Protothecosis is an uncommon disease caused by algae of the genus Prototheca . In dogs, the infection is usually first localized to the colon but has the propensity to later disseminate hematogenously to many other organs, with marked tropism for the eyes and central nervous system. Diagnosis is established by culture and/or evidence of Prototheca organisms in cytologic or histologic preparations. Species characterization, however, requires molecular investigations. Our laboratory set up a real-time PCR targeting portion D1/D2 of the 28S rRNA for identification of Prototheca species from both positive cultures (of rectal swabs and urine) and formalin-fixed, paraffin-embedded tissue. Prototheca bovis , P. ciferrii , and P. wickerhamii were characterized in 11 dogs with systemic or cutaneous protothecosis. Prototheca identifications were phylogenetically consistent with the new taxonomy proposed for this genus based on the mitochondrial cytochrome b gene. As a pilot study, we screened feces and rectal scrapes from 200 asymptomatic dogs, using 2 cohorts of stray and owned animals, to determine the prevalence of intestinal carriage of Prototheca spp. The Prototheca -negative results from both cohorts of healthy dogs suggest that predisposing factors related to the host probably contribute more to the acquisition of clinical disease than exposure to contaminated environments.
- Published
- 2021
- Full Text
- View/download PDF
26. COVID-19: An overview for dermatologists.
- Author
-
Sanghvi AR
- Subjects
- Betacoronavirus isolation & purification, COVID-19, Communicable Disease Control instrumentation, Communicable Disease Control methods, Communicable Disease Control standards, Coronavirus Infections complications, Coronavirus Infections diagnosis, Coronavirus Infections prevention & control, Dermatitis, Contact diagnosis, Dermatitis, Contact etiology, Dermatology standards, Hand Hygiene standards, Humans, Pandemics prevention & control, Personal Protective Equipment adverse effects, Personal Protective Equipment standards, Pneumonia, Viral complications, Pneumonia, Viral diagnosis, Pneumonia, Viral prevention & control, SARS-CoV-2, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious virology, Betacoronavirus pathogenicity, Coronavirus Infections epidemiology, Dermatitis, Contact epidemiology, Dermatology trends, Pneumonia, Viral epidemiology, Skin Diseases, Infectious epidemiology
- Abstract
Numerous unexplained pneumonia cases were reported to the World Health Organization (WHO) by Wuhan, China, in December 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a zoonotic pathogen, came into sight, spreading coronavirus disease 2019 (COVID-19) all over the globe. Association of cutaneous signs and symptoms with COVID-19 is being studied worldwide, principally, to determine if these dermatoses can help in early recognition of SARS-CoV-2 infection. These dermatological manifestations can range from erythematous rash, urticaria to livedo reticularis, and acrocyanosis in patients of all age groups. Correspondingly, dermatologists treating COVID-19 patients, suffering from inflammatory dermatoses, with biologics or immunomodulators should exert caution and use specific protocols to adjust the doses of these medications. Prevention of person-to-person transmission of COVID-19 is being promoted universally, with the use of personal protective equipment (PPE), hand washes, and hand sanitizers around the clock. However, an array of cutaneous adverse effects such as contact dermatitis, irritant contact dermatitis, friction blisters, contact urticaria, acne, and infections are associated with the use of PPE. Extra-pulmonary manifestations of COVID-19 are still emerging in the community, and physicians and researchers are working together globally to strengthen the clinical management of these patients. Cases of COVID-19 continue to rise across the world, and an unprecedented approach has been taken to develop effective vaccines and therapeutic strategies against existing and forthcoming mutagenic strains of SARS-CoV-2., (© 2020 the International Society of Dermatology.)
- Published
- 2020
- Full Text
- View/download PDF
27. Infectious diseases of the skin in contact sports.
- Author
-
Nowicka D, Bagłaj-Oleszczuk M, and Maj J
- Subjects
- Humans, Skin, Skin Diseases diagnosis, Skin Diseases epidemiology, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious epidemiology, Sports
- Abstract
Although the benefits of practicing sports are unquestionable, it can contribute to the spread of skin diseases. Mechanical trauma, exposure to environmental and infectious agents, and contact with the skin of other athletes increase the chances of getting an infection. In contact sports, skin infections are responsible for up to 20% of lost training and competition time. In the USA, skin infections, with an incidence of 8.5-20.9%, are the 2nd cause (following upper respiratory infections) of all medical consultations among young wrestlers. The high morbidity of skin diseases poses a great challenge for the diagnosis and treatment of skin infections in athletes practicing contact sports, for whom recommendations may differ from those in the general population. In this review paper, we summarize and discuss the management of infectious diseases of the skin in contact sports. The review shows that the most frequent among athletes are bacterial infections, including folliculitis, erysipelas, furuncles and inflammation of the subcutaneous tissue; viral infections caused by herpes simplex virus, human papilloma virus and molluscum contagiosum virus; fungal infections such as tinea; and infestations, including pediculosis and scabies. Preventing the spread of the infection is the 2nd most important aspect of treatment, following pharmacotherapy. This includes avoiding contact with other athletes, protection or removal of lesions, disinfection of common sports equipment, not sharing towels or other personal equipment. We conclude that protecting against infection and transmission of pathogens in sports teams is crucial in avoiding unnecessary morbidity and minimizing disruption to the training and competition schedule.
- Published
- 2020
- Full Text
- View/download PDF
28. Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia.
- Author
-
Colledge S, Larney S, Bruno R, Gibbs D, Degenhardt L, Yuen WS, Dietze P, and Peacock A
- Subjects
- Adult, Australia, Female, Humans, Injections adverse effects, Male, Middle Aged, Needles adverse effects, Risk-Taking, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious psychology, Soft Tissue Infections diagnosis, Soft Tissue Infections psychology, Substance Abuse, Intravenous diagnosis, Substance Abuse, Intravenous psychology, Venous Thrombosis diagnosis, Venous Thrombosis psychology, Drug Users psychology, Self Report, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Substance Abuse, Intravenous epidemiology, Venous Thrombosis epidemiology
- Abstract
Introduction: People who inject drugs (PWID) commonly experience harms related to their injecting, many of which are consequences of modifiable drug use practices. There is currently a gap in our understanding of how certain injecting-related injuries and diseases (IRID) cluster together, and socio-demographic and drug use characteristics associated with more complex clinical profiles., Method: Surveys were conducted with 902 Australian PWID in 2019. Participants provided information regarding their drug use, and past month experience of the following IRID: artery injection, nerve damage, skin and soft tissue infection, thrombophlebitis, deep vein thrombosis, endocarditis, septic arthritis, osteomyelitis, and septicaemia. We performed a latent class analysis, grouping participants based on reported IRID and ran a class-weighted regression analysis to determine variables associated with class-membership., Results: One-third (34 %) of the sample reported any IRID. A 3-class model identified: 1) no IRID (73 %), moderate IRID (21 %), and 3) high IRID (6%) clusters. Re-using one`s own needles was associated with belonging to the high IRID versus moderate IRID class (ARRR = 2.38; 95 % CI = 1.04-5.48). Other factors, including daily injecting and past 6-month mental health problems were associated with belonging to moderate and high IRID classes versus no IRID class., Conclusion: A meaningful proportion of PWID reported highly complex IRID presentations distinguished by the presence of thrombophlebitis and associated with greater re-use of needles. Increasing needle and syringe coverage remains critical in addressing the harms associated with injecting drug use and expanding the capacity of low-threshold services to address less severe presentations might aid in reducing IRID amongst PWID., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
29. The infection rate of intralesional triamcinolone and the safety of compounding in dermatology for intradermal and subcutaneous injection: A retrospective medical record review.
- Author
-
Luther CA, Griffith JL, Kurland E, Al Shabeeb R, Eleryan M, Redbord K, and Ozog DM
- Subjects
- Ambulatory Care Facilities, Humans, Incidence, Injections, Intralesional statistics & numerical data, Injections, Subcutaneous statistics & numerical data, Medical Records, Michigan epidemiology, Retrospective Studies, Skin Diseases drug therapy, Skin Diseases, Infectious etiology, Anti-Inflammatory Agents administration & dosage, Drug Compounding statistics & numerical data, Skin Diseases, Infectious epidemiology, Triamcinolone administration & dosage
- Abstract
Background: Intralesional injection of sterile medications remains a mainstay in dermatology, enabling a tailored, low-cost, in-office therapy. After the 2012 United States outbreak of fungal meningitis from contaminated intrathecally administered corticosteroids, there has been increased regulation of in-office compounding, regardless of the administration route. Studies demonstrating the safety data of in-office corticosteroid compounding for intradermal or subcutaneous use are lacking., Objective: To assess the incidence of infection caused by compounded in-office intralesional triamcinolone., Methods: A retrospective medical record review identified patients who received in-office intralesional corticosteroid injections in 2016. Medical documentation within 30 days of injection was reviewed for suspected infection., Results: The records of 4370 intralesional triamcinolone injections were assessed, of which 2780 (64%) were compounded triamcinolone with bacteriostatic saline. We identified 11 (0.25%) suspected localized infections, with 4 of the 11 in the compounding cohort. Of these, 7 of 11 occurred after injection of an "inflamed cyst." No hospitalizations or deaths occurred. No temporal or locational relationships were identified., Limitations: This study was limited to 2 academic institutions. A 30-day postinjection time frame was used., Conclusion: In-office compounding for intralesional dermal and subcutaneous administration is safe when sterile products are used by medical practitioners. There is no increased risk of compounded triamcinolone relative to noncompounded triamcinolone., (Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. Cutaneous Manifestations of COVID-19: An Evidence-Based Review.
- Author
-
Daneshgaran G, Dubin DP, and Gould DJ
- Subjects
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2, Skin Diseases, Infectious epidemiology, Coronavirus Infections complications, Pneumonia, Viral complications, Skin Diseases, Infectious virology
- Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has affected 18 million people and killed over 690,000 patients. Although this virus primarily causes respiratory symptoms, an increasing number of cutaneous manifestations associated with this disease have been reported., Objective: The aim of this review was to collate and categorize the dermatologic findings reported in patients with COVID-19 and identify specific lesions that may facilitate diagnosis and prognostication., Methods: An evidence-based review of the PubMed database was conducted on 14 May, 2020 using the search terms "Covid-19 skin," "Covid-19 rash," "Covid-19 exanthem," and "Covid-19 chilblains." Peer-reviewed publications containing original COVID-19 patient cases and a discussion of the associated cutaneous findings were included in the analysis., Results: The literature search identified 115 records, of which 34 publications describing 996 patients with dermatologic conditions were included. Case reports (n = 15), case series (n = 13), and observational prospective studies (n = 4) were the most common publication types. Acral lesions resembling pseudo-chilblains were the most frequent lesion identified (40.4% of cases), appearing in young adults (mean age, 23.2 years) after the onset of extracutaneous COVID-19 symptoms (55/100 patients). Erythematous maculopapular rashes affected 21.3% of patients, most frequently impacting middle-aged adults (mean age, 53.2 years) and occurring at the same time as non-cutaneous symptoms (110/187 patients). Vesicular rashes affected 13.0% of patients, appearing in middle-aged adults (mean age, 48.3 years) after the onset of other symptoms (52/84 patients). Urticarial rashes affected 10.9% of patients, appearing in adults (mean age, 38.3 years) and occurring at the same time as non-cutaneous symptoms (46/78 patients). Vascular rashes resembling livedo or purpura were uncommon (4% of cases), appearing in elderly patients (mean age, 77.5 years) and occurring at the same time as non-cutaneous COVID-19 symptoms (18/29 patients). Erythema multiforme-like eruptions, although infrequent (3.7% of cases), affected mostly children (mean age, 12.2 years)., Conclusions: Vesicular rashes may suggest an initial diagnosis of COVID-19, acral lesions may be most appropriate for epidemiological uses, and vascular rashes may be a useful prognostic marker for severe disease. As a potential correlate to disease severity, prognosis, or infectibility, it is critical that all healthcare professionals be well versed in these increasingly common cutaneous manifestations of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
31. National Public Health Burden Estimates of Endocarditis and Skin and Soft-Tissue Infections Related to Injection Drug Use: A Review.
- Author
-
See I, Gokhale RH, Geller A, Lovegrove M, Schranz A, Fleischauer A, McCarthy N, Baggs J, and Fiore A
- Subjects
- Drug Users statistics & numerical data, Endocarditis, Bacterial etiology, Humans, Skin Diseases, Infectious etiology, Soft Tissue Infections etiology, United States epidemiology, Cost of Illness, Endocarditis, Bacterial mortality, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Substance Abuse, Intravenous complications
- Abstract
Background: Despite concerns about the burden of the bacterial and fungal infection syndromes related to injection drug use (IDU), robust estimates of the public health burden of these conditions are lacking. The current article reviews and compares data sources and national burden estimates for infective endocarditis (IE) and skin and soft-tissue infections related to IDU in the United States., Methods: A literature review was conducted for estimates of skin and soft-tissue infection and endocarditis disease burden with related IDU or substance use disorder terms since 2011. A range of the burden is presented, based on different methods of obtaining national projections from available data sources or published data., Results: Estimates using available data suggest the number of hospital admissions for IE related to IDU ranged from 2900 admissions in 2013 to more than 20 000 in 2017. The only source of data available to estimate the annual number of hospitalizations and emergency department visits for skin and soft-tissue infections related to IDU yielded a crude estimate of 98 000 such visits. Including people who are not hospitalized, a crude calculation suggests that 155 000-540 000 skin infections related to IDU occur annually., Discussion: These estimates carry significant limitations. However, regardless of the source or method, the burden of disease appears substantial, with estimates of thousands of episodes of IE among persons with IDU and at least 100 000 persons who inject drugs (PWID) with skin and soft-tissue infections annually in the United States. Given the importance of these types of infections, more robust and reliable estimates are needed to better quantitate the occurrence and understand the impact of interventions., (Published by Oxford University Press for the Infectious Diseases Society of America 2020.)
- Published
- 2020
- Full Text
- View/download PDF
32. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
- Author
-
Loftus MJ, Curtis SJ, Naidu R, Cheng AC, Jenney AWJ, Mitchell BG, Russo PL, Rafai E, Peleg AY, and Stewardson AJ
- Subjects
- Adolescent, Adult, Female, Fiji epidemiology, Humans, Infant, Newborn, Infection Control methods, Male, Middle Aged, Practice Guidelines as Topic, Prevalence, Socioeconomic Factors, Surveys and Questionnaires, Tertiary Care Centers, Young Adult, Cross Infection epidemiology, Drug Resistance, Multiple, Drug Utilization statistics & numerical data, Sepsis epidemiology, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Surgical Wound Infection epidemiology
- Abstract
Background: Healthcare-associated infections (HAIs) and antimicrobial use (AMU) are important drivers of antimicrobial resistance, yet there is minimal data from the Pacific region. We sought to determine the point prevalence of HAIs and AMU at Fiji's largest hospital, the Colonial War Memorial Hospital (CWMH) in Suva. A secondary aim was to evaluate the performance of European Centre for Diseases Prevention and Control (ECDC) HAI criteria in a resource-limited setting., Methods: We conducted a point prevalence survey of HAIs and AMU at CWMH in October 2019. Survey methodology was adapted from the ECDC protocol. To evaluate the suitability of ECDC HAI criteria in our setting, we augmented the survey to identify patients with a clinician diagnosis of a HAI where diagnostic testing criteria were not met. We also assessed infection prevention and control (IPC) infrastructure on each ward., Results: We surveyed 343 patients, with median (interquartile range) age 30 years (16-53), predominantly admitted under obstetrics/gynaecology (94, 27.4%) or paediatrics (83, 24.2%). Thirty patients had one or more HAIs, a point prevalence of 8.7% (95% CI 6.0% to 12.3%). The most common HAIs were surgical site infections (n = 13), skin and soft tissue infections (7) and neonatal clinical sepsis (6). Two additional patients were identified with physician-diagnosed HAIs that failed to meet ECDC criteria due to insufficient investigations. 206 (60.1%) patients were receiving at least one antimicrobial. Of the 325 antimicrobial prescriptions, the most common agents were ampicillin (58/325, 17.8%), cloxacillin (55/325, 16.9%) and metronidazole (53/325, 16.3%). Use of broad-spectrum agents such as piperacillin/tazobactam (n = 6) and meropenem (1) was low. The majority of prescriptions for surgical prophylaxis were for more than 1 day (45/76, 59.2%). Although the number of handwashing basins throughout the hospital exceeded World Health Organization recommendations, availability of alcohol-based handrub was limited and most concentrated within high-risk wards., Conclusions: The prevalence of HAIs in Fiji was similar to neighbouring high-income countries, but may have been reduced by the high proportion of paediatric and obstetrics patients, or by lower rates of inpatient investigations. AMU was very high, with duration of surgical prophylaxis an important target for future antimicrobial stewardship initiatives.
- Published
- 2020
- Full Text
- View/download PDF
33. Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK.
- Author
-
Wright T, Hope V, Ciccarone D, Lewer D, Scott J, and Harris M
- Subjects
- Abscess complications, Abscess physiopathology, Adult, Cellulitis complications, Cellulitis physiopathology, Female, Humans, London epidemiology, Male, Middle Aged, Outcome Assessment, Health Care, Patient Acceptance of Health Care, Prevalence, Risk Factors, Sepsis complications, Sepsis epidemiology, Sepsis physiopathology, Skin Diseases, Infectious complications, Skin Diseases, Infectious physiopathology, Substance Abuse, Intravenous complications, Substance Abuse, Intravenous physiopathology, United Kingdom epidemiology, Abscess epidemiology, Cellulitis epidemiology, Skin Diseases, Infectious epidemiology, Substance Abuse, Intravenous epidemiology
- Abstract
Background: Skin and soft tissue infections (SSTI) are a common but preventable cause of morbidity and mortality among people who inject drugs (PWID). They can be severe, and hospitalisations of PWID with SSTI are rising. The most common SSTI presentations are abscesses and cellulitis., Methods: We used data from Care & Prevent, a cross-sectional community survey of PWID in London. We reported the lifetime prevalence of SSTI, severity of infections, key risk factors, and associated sequelae. Pictorial questions were used to assess SSTI severity., Results: We recruited 455 PWID. SSTI lifetime prevalence was high: 64% reported an abscess and/or cellulitis. Over one-third (37%) reported a severe infection, 137 (47%) reported hospitalisation. SSTIrisk factors were: aged 35+ years, injecting once or more times a day, subcutaneous or intra-muscular injections, and making four or more attempts to achieve an injection. Those who reported having other health conditions were at higher odds of having an abscess or cellulitis, with risk tending to increase with number of reported conditions. Half (46%) employed self-care for their worst SSTI, and 43% waited for ten or more days before seeking medical care or not seeking medical care at all., Conclusions: Abscess and cellulitis are very common among PWID in London. We corroborate findings indicating SSTIs are associated with risks, e.g. venous access problems, as well as other co-morbid conditions: septicaemia, endocarditis, DVT, and kidney disease. These co-morbidities may impact SSTIs severity and outcomes. Delayed healthcare seeking potentially exacerbates infection severity, which in turn increases poorer health outcomes and complications., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
34. Update on the cutaneous manifestations of COVID-19.
- Author
-
Hoenig LJ
- Subjects
- COVID-19, Humans, Pandemics, SARS-CoV-2, Severity of Illness Index, Skin Diseases, Infectious epidemiology, Betacoronavirus, Coronavirus Infections epidemiology, Pneumonia, Viral epidemiology, Skin Diseases, Infectious virology
- Published
- 2020
- Full Text
- View/download PDF
35. National Trends in Incidence of Purulent Skin and Soft Tissue Infections in Patients Presenting to Ambulatory and Emergency Department Settings, 2000-2015.
- Author
-
Fritz SA, Shapiro DJ, and Hersh AL
- Subjects
- Anti-Bacterial Agents therapeutic use, Cephalexin, Emergency Service, Hospital, Humans, Incidence, Skin Diseases, Infectious drug therapy, Skin Diseases, Infectious epidemiology, Soft Tissue Infections drug therapy, Soft Tissue Infections epidemiology
- Abstract
Nationally representative data from 2000-2015 demonstrated a rise in the incidence of outpatient visits for skin infections, peaking in 2010-2013, followed by a plateau. While cephalexin was the most frequently prescribed antibiotic at the beginning, trimethoprim-sulfamethoxazole was most frequently prescribed by the end of the study period., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
36. 12-year data on dermatologic cases in the Finnish Register of Occupational Diseases I: Distribution of different diagnoses and main causes of allergic contact dermatitis.
- Author
-
Aalto-Korte K, Koskela K, and Pesonen M
- Subjects
- Acrylates adverse effects, Adult, Dermatitis, Irritant etiology, Epoxy Compounds adverse effects, Epoxy Resins adverse effects, Female, Finland epidemiology, Hair Preparations adverse effects, Humans, Incidence, Isocyanates adverse effects, Male, Metals adverse effects, Middle Aged, Preservatives, Pharmaceutical adverse effects, Registries, Rubber adverse effects, Skin Diseases, Infectious epidemiology, Thiazoles adverse effects, Urticaria epidemiology, Dermatitis, Allergic Contact epidemiology, Dermatitis, Allergic Contact etiology, Dermatitis, Irritant epidemiology, Dermatitis, Occupational epidemiology, Dermatitis, Occupational etiology
- Abstract
Background: Skin diseases are among the most common occupational diseases, but detailed analyses on their epidemiology, diagnoses, and causes are relatively scarce., Objectives: To analyze data on skin disease in the Finnish Register of Occupational Diseases (FROD) for (1) different diagnoses and (2) main causes of allergic contact dermatitis (ACD)., Methods: We retrieved data on recognized cases with occupational skin disease (OSD) in the FROD from a 12-year-period 2005-2016 and used national official labor force data of the year 2012., Results: We analyzed a total of 5265 cases, of which 42% had irritant contact dermatitis (ICD), 35% ACD, 11% contact urticaria/protein contact dermatitis (CU/PCD), and 9% skin infections. The incidence rate of OSD in the total labor force was 18.8 cases/100 000 person years. Skin infections concerned mainly scabies in health care personnel. Twenty-nine per cent of the ACD cases were caused by plastics/resins-related allergens, mainly epoxy chemicals. Other important causes for ACD were rubber, preservatives, metals, acrylates, and hairdressing chemicals. Cases of occupational ACD due to isothiazolinones reached a peak in 2014., Conclusion: Our analysis confirms that epoxy products are gaining importance as causes of OSD and the isothiazolinone contact allergy epidemic has started to wane., (© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
37. Skin barrier immunity and ageing.
- Author
-
Chambers ES and Vukmanovic-Stejic M
- Subjects
- Adipocytes immunology, Disease Susceptibility, Fibroblasts immunology, Humans, Incidence, Keratinocytes immunology, Langerhans Cells immunology, Macrophages immunology, Microbiota immunology, Skin cytology, Skin microbiology, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious microbiology, Skin Neoplasms epidemiology, Water Loss, Insensible immunology, Aging immunology, Immunity, Cellular, Skin immunology, Skin Diseases, Infectious immunology, Skin Neoplasms immunology
- Abstract
The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m
2 , and is the first line of defence against a multitude of external pathogens and environmental insults. The skin also has important homeostatic functions such as reducing water loss and contributing to thermoregulation of the body. The structure of the skin and its cellular composition work in harmony to prevent infections and to deal with physical and chemical challenges from the outside world. In this review, we discuss how the structural cells such as keratinocytes, fibroblasts and adipocytes contribute to barrier immunity. We also discuss specialized immune cells that are resident in steady-state skin including mononuclear phagocytes, such as Langerhans cells, dermal macrophages and dermal dendritic cells in addition to the resident memory T cells. Ageing results in an increased incidence of cancer and skin infections. As we age, the skin structure changes with thinning of the epidermis and dermis, increased water loss, and fragmentation of collagen and elastin. In addition, the skin immune composition is altered with reduced Langerhans cells, decreased antigen-specific immunity and increased regulatory populations such as Foxp3+ regulatory T cells. Together, these alterations result in decreased barrier immunity in the elderly, explaining in part their increased susceptiblity to cancer and infections., (© 2019 John Wiley & Sons Ltd.)- Published
- 2020
- Full Text
- View/download PDF
38. Spectrum of skin diseases in Amerindian villages of the Upper Oyapock, French Guiana.
- Author
-
Malmontet T, Guarmit B, Gaillet M, Michaud C, Garceran N, Chanlin R, Demar M, Couppie P, and Blaizot R
- Subjects
- Adolescent, Adult, Aged, Bites and Stings etiology, Child, Child, Preschool, Female, French Guiana epidemiology, Humans, Infant, Male, Medical Records statistics & numerical data, Middle Aged, Prevalence, Retrospective Studies, Skin Diseases, Infectious microbiology, Skin Diseases, Infectious parasitology, Young Adult, Bites and Stings epidemiology, Eczema epidemiology, Indians, South American statistics & numerical data, Sexually Transmitted Diseases epidemiology, Skin Diseases, Infectious epidemiology, Skin Neoplasms epidemiology
- Abstract
Background: Due to their genetic characteristics, their isolation in rainforest areas, and their traditional way of life, Amerindian populations are likely to suffer from a specific spectrum of dermatoses. However, there are few available data on such skin disorders. Our aims were to describe all skin disorders in two Amerindian villages of French Guiana., Methods: This retrospective study concerned all patients who consulted in the Health Centres of Camopi and Trois-Sauts between July 1, 2017, and December 31, 2018. We included all patients classified with an ICD code linked to a skin disorder. All medical records were cross-checked by two dermatologists to correct misclassifications., Results: A total of 639 patients formed the study population, for 866 different skin disorders. Non-sexually transmitted infections represented 57.6% of all skin disorders, followed by eczema (11.5%) and bites/envenomations (9.1%). Bacteria were responsible for 238 skin infections, followed by fungi (141 cases) and parasites (69 cases, including 43 scabies, nine cutaneous leishmaniasis, and two tungiasis). We reported a low prevalence of sexually transmitted infections (10 cases) and an absence of skin cancers., Conclusions: This study revealed the absence of skin cancer in the Amerindian population of the Upper Oyapock and the important burden of infectious and animal-related diseases. Future studies should assess a possible underestimation of sexually transmitted diseases in this area. Public health policies should target neglected diseases such as cutaneous leishmaniasis, tungiasis, scabies, and envenomations. Atopic dermatitis was a significant and unexpected cause of consultations., (© 2020 The Authors. International Journal of Dermatology published by Wiley Periodicals, Inc. on behalf of International Society of Dermatology.)
- Published
- 2020
- Full Text
- View/download PDF
39. Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017.
- Author
-
Huang DB, Charrier C, and Hawser S
- Subjects
- Africa epidemiology, Asia epidemiology, Europe epidemiology, Folic Acid Antagonists, Global Health statistics & numerical data, Gram-Positive Bacteria enzymology, Gram-Positive Bacteria pathogenicity, Gram-Positive Bacterial Infections epidemiology, Gram-Positive Bacterial Infections microbiology, Humans, Latin America epidemiology, Microbial Sensitivity Tests, Middle East epidemiology, Skin Diseases, Infectious epidemiology, Tetrahydrofolate Dehydrogenase metabolism, United States epidemiology, Anti-Bacterial Agents pharmacology, Gram-Positive Bacteria drug effects, Population Surveillance, Pyrimidines pharmacology, Skin microbiology, Skin Diseases, Infectious microbiology
- Abstract
Iclaprim is a novel diaminopyrimidine, which inhibits bacterial dihydrofolate reductase, and it is active against Gram-positive pathogens including emerging drug-resistant pathogens. In vitro activity of iclaprim and comparators against 1365 Gram-positive clinical isolates from patients with skin and skin structure infections (SSSI) from the United States, Asia Pacific, Latin America, Europe, Africa or Middle East collected between 2013 and 2017 were tested. Susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Minimum inhibitory concentration (MIC) interpretations were based on CLSI criteria. MIC
90 for all S.aureus, methicillin-susceptible S. aureus, methicillin-resistant S. aureus, Streptococcus pyogenes, S. agalactiae, S. anginosus, S. constellatus, S. dysgalactiae and S. intermedius were 0.12, 0.12, 0.5, 0.03, 0.5, ≤0.004, ≤0.004, 0.12, and 0.008 μg/ml, respectively. The MIC for iclaprim was 8 to 32-fold lower than trimethoprim, the only FDA approved dihydrofolate reductase inhibitor, against all Gram-positive isolates including resistant phenotypes. Iclaprim demonstrated lower MICs than trimethoprim against a collection (2013-2017) of Gram-positive clinical isolates from patients with SSSI from the United States, Asia Pacific, Latin America, and Europe., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
40. Predictors of hospital readmission in United States adults with psoriasis.
- Author
-
Cheng BT and Silverberg JI
- Subjects
- Adolescent, Adult, Comorbidity, Databases, Factual statistics & numerical data, Female, Forecasting, Hospital Costs statistics & numerical data, Hospital Costs trends, Humans, Length of Stay economics, Length of Stay statistics & numerical data, Length of Stay trends, Longitudinal Studies, Male, Middle Aged, Patient Readmission economics, Patient Readmission statistics & numerical data, Psoriasis epidemiology, Psoriasis immunology, Psoriasis therapy, Risk Factors, Skin Diseases, Infectious economics, Skin Diseases, Infectious immunology, Skin Diseases, Infectious therapy, Time Factors, United States epidemiology, Young Adult, Cost of Illness, Patient Readmission trends, Psoriasis economics, Skin Diseases, Infectious epidemiology
- Abstract
Background: Previous studies showed a large inpatient burden of psoriasis in the United States. Less is known about the hospital readmission for psoriasis., Objectives: To determine the patterns and predictors of hospital readmission rates for psoriasis., Methods: We analyzed data from the 2012-2014 Nationwide Readmissions Database, a representative sample of hospital readmissions in the United States., Results: Among 2606 admissions for psoriasis, 216 had ≥1 readmissions for psoriasis (prevalence [95% confidence interval]: 8.3% [6.6%-10.0%]) and 918 for all-causes (35.2% [32.2%-38.3%]). The mean annual cost of first readmission for any reason was $3,500,141, with $8,357,961 for subsequent readmissions. In multivariable regression models, readmission for psoriasis was associated with ≥6 day-long index hospitalization (adjusted hazard ratio [95% confidence interval]: 1.82 [1.06-3.12]), teaching hospital (1.93 [1.13-3.31]), comorbid skin infection (2.13 [1.11-4.08]), and hospitalization in the autumn (4.51 [2.54-8.00]), but inversely associated with other infections (0.49 [0.26-0.92]). Readmissions for psoriasis increased from 2012 to 2014 (1.93 [1.26-2.93])., Limitations: No data on psoriasis characteristics., Conclusion: Inpatients with psoriasis had high rates of readmission overall but low rates of readmission for psoriasis per se. A subset of psoriasis patients was hospitalized repeatedly and responsible for most inpatients costs. Future interventions are needed to lower readmission rates among psoriasis patients., (Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
41. Infections as a Risk Factor for and Prognostic Factor After Substance-Induced Psychoses.
- Author
-
Hjorthøj C, Starzer MSK, Benros ME, and Nordentoft M
- Subjects
- Adolescent, Adult, Central Nervous System Infections epidemiology, Denmark epidemiology, Disease Progression, Female, Gastroenteritis epidemiology, Hepatitis epidemiology, Humans, Incidence, Male, Prognosis, Proportional Hazards Models, Reproductive Tract Infections epidemiology, Respiratory Tract Infections epidemiology, Risk Factors, Sepsis epidemiology, Skin Diseases, Infectious epidemiology, Urinary Tract Infections epidemiology, Young Adult, Infections epidemiology, Psychoses, Substance-Induced epidemiology, Schizophrenia epidemiology
- Abstract
Objective: Previous studies have suggested that infections increase the risk of schizophrenia. In this study, the authors aimed to investigate 1) whether infections increase the risk of substance-induced psychosis, and 2) whether infections increase the risk of converting from substance-induced psychosis to schizophrenia., Methods: The study data were drawn from the combined nationwide Danish registers and included all people born in Denmark since 1981. The authors used Cox proportional hazards regression with infections as time-varying covariates, estimating hazard ratios and 95% confidence intervals. Infections were operationalized both as any infection and by the site of infection., Results: The study included 2,256,779 individuals, for whom 3,618 cases of incident substance-induced psychosis were recorded. Any infection increased the risk of substance-induced psychosis (hazard ratio=1.30, 95% CI=1.22-1.39). For the first 2 years, the risk was doubled. Hepatitis was the infection most strongly associated with substance-induced psychosis (hazard ratio=3.42, 95% CI=2.47-4.74). Different types of infections were linked with different types of substance-induced psychosis. Most associations remained significant after controlling for potential confounders, such as substance use disorders. Only hepatitis predicted conversion to schizophrenia after substance-induced psychosis (hazard ratio=1.87, 95% CI=1.07- 3.26)., Conclusions: The study results support the hypothesis of an immunological component to psychosis.
- Published
- 2020
- Full Text
- View/download PDF
42. Infection prevention and control challenges in Flemish homecare nursing: a pilot study.
- Author
-
Maelegheer K, Dumitrescu I, Verpaelst N, Masson H, Broucke C, Braekeveld P, Backaert D, Mensaert C, Leroux-Roels I, and Floré K
- Subjects
- Adult, Aged, Aged, 80 and over, Belgium epidemiology, Comorbidity, Drug Resistance, Multiple, Equipment and Supplies microbiology, Female, Humans, Male, Middle Aged, Pilot Projects, Prevalence, Risk Factors, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology, Urinary Tract Infections epidemiology, Wounds and Injuries microbiology, Home Nursing standards, Hygiene, Skin Diseases, Infectious prevention & control, Soft Tissue Infections prevention & control, Urinary Tract Infections prevention & control, Wounds and Injuries nursing
- Abstract
Home nursing is evolving towards more invasive care. Nevertheless, no national data are available on the prevalence of HAI in this setting. The aim of this pilot study is to explore the Flemish home care setting as a first step toward a national surveillance program. A survey, focused on patient characteristics and HAI, was conducted between 7 May and 20 July 2018 on 711 Flemish patients. Most of the patients (74%) are 65 years or older and half of them had a form of comorbidity. Assisting with personal hygiene and wound care were the most frequent services delivered by home care nurses. A comparison of the prevalence of infections diagnosed by a physician or applying uniform criteria (ECDC), revealed a similar prevalence of skin and soft tissue infections (9% vs. 8.5%) and urinary tract infections (4% vs. 4.5%). A positive MDRO-screening was found in 6% of the patients. This pilot study is a first step towards a standardized national surveillance in home care to collect information on the prevalence of HAI and it reveals several interesting facts and study pitfalls for this setting.
- Published
- 2020
- Full Text
- View/download PDF
43. Skin infections in Australian Aboriginal children: a narrative review.
- Author
-
Davidson L, Knight J, and Bowen AC
- Subjects
- Australia epidemiology, Child, Humans, Native Hawaiian or Other Pacific Islander, Skin Diseases, Infectious complications, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious therapy
- Abstract
Impetigo, scabies, cellulitis and abscesses are common in Australian Aboriginal children. These conditions adversely affect wellbeing and are associated with serious long term sequelae, including invasive infection and post-infectious complications, such as acute post-streptococcal glomerulonephritis and acute rheumatic fever, which occurs at the highest documented rates in the world in remote Aboriginal communities. Observational research in remote communities in northern Australia has demonstrated a high concurrent burden of scabies and impetigo and their post-infectious complications. Few data are available for other Australian states, especially for urban Aboriginal children; however, nationwide hospital data indicate that the disparity between Aboriginal and non-Aboriginal children in skin infection prevalence also exists in urban settings. The Australian National Healthy Skin Guideline summarises evidence-based treatment of impetigo, scabies and fungal infections in high burden settings such as remote Aboriginal communities. It recommends systemic antibiotics for children with impetigo, and either topical permethrin or oral ivermectin (second line) for the individual and their contacts as equally efficacious treatments for scabies. β-Lactams are the treatment of choice and trimethoprim-sulfamethoxazole and clindamycin are effective alternatives for treatment of paediatric cellulitis. Abscesses require incision and drainage and a 5-day course of trimethoprim-sulfamethoxazole or clindamycin. Addressing normalisation of skin infections and the social determinants of skin health are key challenges for the clinician. Research is underway on community-wide skin health programs and the role for mass drug administration which will guide future management of these common, treatable diseases., (© 2019 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
44. Infection Rates Before and After Diagnosis of IgA Vasculitis in Childhood: A Population-wide Study Using Non-exposed Matched Controls.
- Author
-
Nossent JC, Raymond W, Keen H, Preen DB, and Inderjeeth CA
- Subjects
- Adolescent, Adult, Australia epidemiology, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Incidence, Male, Prevalence, Risk Factors, Young Adult, IgA Vasculitis diagnosis, Pneumonia epidemiology, Sepsis epidemiology, Skin Diseases, Infectious epidemiology
- Abstract
Objective: Clinical data suggest that infections can trigger IgA vasculitis (IgAV), but longterm observations are lacking. We compared rates, types, and microorganisms for serious infection before and after diagnosis for children with IgAV and non-exposed controls., Methods: Using population-based administrative linked health datasets we estimated incidence rates (IR) for serious infection per 1000 person-months for patients with IgAV (n = 504, age 5 yrs, 59.1% males) and controls matched for age, sex, and year of presentation (n = 1281, age 6 yrs, 66% males). Time zero (T0) was the date of IgAV diagnosis or equivalent date in controls, lookback (median 38 mos) was the period prior to T0, and followup (median 239 mos) was the period after T0., Results: During lookback, prevalence of serious infection was similar in patients with IgAV and controls (11.5% vs 9.5%, respectively), but patients with IgAV had a higher rate of upper respiratory tract infections [incidence rate ratio (IRR) 1.79; 95% CI 1.39-2.31] with shorter time between first serious infection and T0 (27 vs 43 mos; p = 0.02). During followup, patients were at a constant increased risk for serious infections (IRR 1.46, 95% CI 1.35-1.58). These rates were higher during followup: sepsis (IRR 12.6), pneumonia (IRR 6.19), upper respiratory tract infections (IRR 2.36), and skin infections (IRR 1.85). There was little overlap between patients with serious infections in the lookback and followup periods., Conclusion: In patients with childhood IgAV there is an increased longterm risk for a broader spectrum of infections, which is unrelated to serious infections prior to diagnosis or treatment. This suggests disease-specific factors may have a lasting effect on immune competence in childhood IgAV.
- Published
- 2020
- Full Text
- View/download PDF
45. Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi-centre study.
- Author
-
Haynes D, Hammer P, Malachowski SJ, Kaffenberger B, Yi JS, Vera N, Calhoun C, Shinohara MM, Seminario-Vidal L, Trinidad JC, Keller JJ, and Ortega-Loayza AG
- Subjects
- Adult, Biopsy statistics & numerical data, Dermatology, Female, Hospitalization, Hospitals, University, Humans, Male, Middle Aged, Pyoderma Gangrenosum diagnosis, Pyoderma Gangrenosum epidemiology, Referral and Consultation, Retrospective Studies, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious epidemiology, United States epidemiology, Skin Ulcer epidemiology, Skin Ulcer etiology
- Abstract
Accurate and prompt diagnosis of skin ulcers is critical to optimise management; however, studies in hospitalised patients are limited. This retrospective review of dermatologic consultations included 272 inpatients with skin ulcers between July 2015 and July 2018 in four U.S. academic hospitals. The median age was 54 years and 45% were male. In 49.3% of the patients, skin ulcers were considered the primary reason for admission. Ulcers of 62% were chronic and 49.6% were located on the lower extremities. Pyoderma gangrenosum (17.3%), infection (12.5%), and exogenous causes (11.8%) were the leading aetiologies; 12% remained diagnostically inconclusive after consultation. Diagnostic agreements pre-dermatology and post-dermatology consult ranged from 0.104 (n = 77, 95% CI 0.051-0.194) to 0.553 (n = 76, 95% CI 0.440-0.659), indicating poor-modest agreement. This study highlights the diagnostic complexity and relative incidences of skin ulcers in the inpatient setting., (© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
46. Comorbidités de la dermatite atopique: Comorbidities of atopic dermatitis.
- Author
-
Cribier B
- Subjects
- Adult, Asthma epidemiology, Autoimmune Diseases epidemiology, Cardiovascular Diseases epidemiology, Child, Comorbidity, Diabetes Mellitus epidemiology, Disease Susceptibility, Eye Diseases epidemiology, Female, Gastrointestinal Diseases epidemiology, Humans, Hypersensitivity, Immediate epidemiology, Male, Mental Disorders epidemiology, Metabolic Syndrome epidemiology, Neoplasms epidemiology, Obesity epidemiology, Osteoporosis epidemiology, Respiratory Tract Diseases epidemiology, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious etiology, Smoking epidemiology, Young Adult, Dermatitis, Atopic epidemiology
- Abstract
Atopic dermatitis is associated with an increased risk of asthma (10 to 30% according to age), allergic rhinitis and conjunctivitis and food allergy. Other comorbidiies are globally lest frequent than in psoriasis. There is no increased risk of solid cancer. Smoking is a major confounding factor that has to be taken into account. Obesity and metabolic syndrome are more frequent and there is a moderately increased cardiovascular risk in severe forms of atopic dermatitis. There is a clear-cut increased risk of vitiligo and alopecia areata and a lower risk of other auto-immune diseases, including type I diabetes in children. There is a higher risk of cutaneous but not extra-cutaneous bacterial and viral infections, and increased frequency of contact dermatitis and urticaria. Severe atopic dermatitis is associated with psychiatric comorbidities, like attention disorders/hyperactivity, depression and suicidal ideas. © 2019 Elsevier Masson SAS. All rights reserved., (Copyright © 2019 Elsevier Masson SAS. Tous droits réservés.)
- Published
- 2019
- Full Text
- View/download PDF
47. Infections in patients with burn injuries receiving extracorporeal membrane oxygenation.
- Author
-
Marcus JE, Piper LC, Ainsworth CR, Sams VG, Batchinsky A, Okulicz JF, and Barsoumian AE
- Subjects
- Adult, Bacteremia epidemiology, Bacteremia microbiology, Burn Units, Burns complications, Burns epidemiology, Candidemia epidemiology, Candidemia microbiology, Candidiasis epidemiology, Candidiasis microbiology, Cross Infection microbiology, Drug Resistance, Bacterial, Female, Gram-Negative Bacterial Infections epidemiology, Gram-Negative Bacterial Infections microbiology, Gram-Positive Bacterial Infections epidemiology, Gram-Positive Bacterial Infections microbiology, Healthcare-Associated Pneumonia epidemiology, Healthcare-Associated Pneumonia microbiology, Hospitals, Military, Humans, Intensive Care Units, Male, Middle Aged, Pneumonia, Bacterial epidemiology, Pneumonia, Bacterial microbiology, Pneumonia, Ventilator-Associated epidemiology, Pneumonia, Ventilator-Associated microbiology, Respiratory Distress Syndrome epidemiology, Respiratory Distress Syndrome etiology, Retrospective Studies, Skin Diseases, Infectious epidemiology, Skin Diseases, Infectious microbiology, Soft Tissue Infections epidemiology, Soft Tissue Infections microbiology, Stevens-Johnson Syndrome complications, Stevens-Johnson Syndrome epidemiology, Stevens-Johnson Syndrome therapy, Time Factors, United States epidemiology, Urinary Tract Infections epidemiology, Urinary Tract Infections microbiology, Wound Infection epidemiology, Wound Infection microbiology, Burns therapy, Cross Infection epidemiology, Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome therapy
- Abstract
Introduction: Extracorporeal Membrane Oxygenation (ECMO) has only recently been described in patients with burn injuries. We report the incidence and type of infections in critically ill burn and non-burn patients receiving ECMO., Methods: A retrospective chart review was performed on all patients at Brooke Army Medical Center who received ECMO between September 2012 and May 2018., Results: 78 patients underwent ECMO. Approximately half were men with a median age of 34 years with a median time on ECMO of 237 h (IQR 121-391). Compared to patients without burns (n = 58), patients with burns (n = 20) had no difference in time on ECMO, but had more overall infections (86 vs. 31 per 1000 days, p = 0.0002), respiratory infections (40 vs. 15 per 1000 days, p = 0.01), skin and soft tissue infections (21 vs. 5 per 1000 days, p = 0.02) and fungal infections (35% vs 10%, p = 0.02). Twenty percent of bacterial burn infections were due to drug resistant organisms., Conclusion: This is the first study to describe the incidence of infection in burn injury patients who are undergoing ECMO. We observed an increase in infections in burn patients on ECMO compared to non-burn patients. ECMO remains a viable option for critically ill patients with burn injuries., (Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
48. Diabetes and the Risk of Infection: A National Cohort Study.
- Author
-
Kim EJ, Ha KH, Kim DJ, and Choi YH
- Subjects
- Aged, Aged, 80 and over, Comorbidity, Diabetes Mellitus mortality, Female, Follow-Up Studies, Hospitalization, Humans, Incidence, Intensive Care Units, Male, Middle Aged, Republic of Korea epidemiology, Retrospective Studies, Risk Factors, Central Nervous System Infections epidemiology, Diabetes Mellitus epidemiology, Liver Abscess epidemiology, Skin Diseases, Infectious epidemiology, Soft Tissue Infections epidemiology
- Abstract
Background: Several studies have shown that people with diabetes are vulnerable to infection. This study compared the risk of infection-related hospitalizations, intensive care unit (ICU) admission, and deaths between the person with diabetes and the general population in South Korea., Methods: We conducted a cohort study of 66,426 diabetes and 132,852 age-sex-region-matched non-diabetes controls from the general population using a sample of data from the National Health Insurance Service-National Sample Cohort. The cohort was followed up for 9 years. Infections were classified into 17 separate categories. We used Poisson regression, with adjustment for household income and other comorbidities, to estimate incidence rate ratios (IRRs) in order to compare of infection-related hospitalizations, ICU admissions, and deaths., Results: Compared to non-diabetes controls, diabetes group had a greater risk of almost all the types of infections considered, with the adjusted IRRs (aIRRs) for infection-related hospitalizations being the highest for hepatic abscess (aIRR, 10.17; 95% confidence interval [CI], 7.04 to 14.67), central nervous system (CNS) infections (aIRR, 8.72; 95% CI, 6.64 to 11.45), and skin and soft tissue infections other than cellulitis (SSTIs) (aIRR, 3.52; 95% CI, 3.20 to 3.88). Diabetes group also had a greater risk of ICU admission and death due to SSTIs (aIRR, 11.75; 95% CI, 7.32 to 18.86), CNS infections (aIRR, 5.25; 95% CI, 3.53 to 7.79), and bone and joint infections (aIRR, 4.78; 95% CI, 3.09 to 7.39)., Conclusion: In South Korea, people with diabetes has a considerably higher incidence of infection-related hospitalizations and deaths than the general population., Competing Interests: No potential conflict of interest relevant to this article was reported., (Copyright © 2019 Korean Diabetes Association.)
- Published
- 2019
- Full Text
- View/download PDF
49. Obesity and risk of infections: results from men and women in the Swedish National March Cohort.
- Author
-
Ghilotti F, Bellocco R, Ye W, Adami HO, and Trolle Lagerros Y
- Subjects
- Adult, Cohort Studies, Female, Gastrointestinal Diseases epidemiology, Humans, Incidence, Male, Middle Aged, Overweight epidemiology, Proportional Hazards Models, Risk Factors, Sepsis epidemiology, Sex Factors, Skin Diseases, Infectious epidemiology, Sweden epidemiology, Thinness epidemiology, Urinary Tract Infections epidemiology, Body Mass Index, Infections epidemiology, Obesity epidemiology
- Abstract
Background: Previous studies have shown an association between body mass index (BMI) and infections, but the literature on type-specific community acquired infections is still limited., Methods: We included 39 163 Swedish adults who completed a questionnaire in September 1997 and were followed through record-linkages until December 2016. Information on BMI was self-reported and infections were identified from the Swedish National Patient Register using International Classification of Diseases (ICD), Tenth Revision (ICD-10) codes. We fitted multivariable Cox proportional hazards models for time-to-first-event analysis, and we used extensions of the standard Cox model when repeated events were included., Results: During a 19-year follow-up 32% of the subjects had at least one infection requiring health care contact, leading to a total of 27 675 events. We found an increased incidence of any infection in obese women [hazard ratio (HR) = 1.22; 95% confidence interval (CI) = 1.12; 1.33] and obese men (HR = 1.25; 95% CI = 1.09; 1.43) compared with normal weight subjects. For specific infections, higher incidences were observed for skin infections in both genders (HR = 1.76; 95% CI = 1.47; 2.12 for obese females and HR = 1.74; 95% CI = 1.33; 2.28 for obese males) and gastrointestinal tract infections (HR = 1.44; 95% CI = 1.19; 1.75), urinary tract infections (HR = 1.30; 95% CI = 1.08; 1.55) and sepsis (HR = 2.09; 95% CI = 1.46; 2.99) in obese females. When accounting for repeated events, estimates similar to the aforementioned ones were found., Conclusions: Obesity was associated with an increased risk of infections in both genders. Results from multiple-failure survival analysis were consistent with those from classic Cox models., (© The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association.)
- Published
- 2019
- Full Text
- View/download PDF
50. Prevalence of skin infections, infestations, and papular urticaria among adolescents in secondary schools in Calabar, Nigeria.
- Author
-
Henshaw EB and Olasode OA
- Subjects
- Adolescent, Animals, Bites and Stings complications, Candidiasis epidemiology, Cross-Sectional Studies, Female, Furunculosis epidemiology, Humans, Male, Nigeria epidemiology, Prevalence, Scabies epidemiology, Schools, Tinea epidemiology, Tinea Versicolor epidemiology, Urticaria etiology, Warts epidemiology, Young Adult, Bites and Stings epidemiology, Insecta, Skin Diseases, Infectious epidemiology, Urticaria epidemiology
- Abstract
Background: Acne is an inflammatory disorder of the pilosebaceous gland, and the most common dermatosis in adolescents globally. Infectious dermatoses are common in the tropics, but due to the paucity of epidemiologic surveys, not much is known about the prevalence and common types found in different sub-populations including adolescents. It is however presumed that the prevalence will be high and the pattern diverse. We therefore conducted a school-based survey to ascertain the prevalence and pattern of infectious dermatoses, infestations, and papular urticaria (insect bite reactions) in teenage adolescents in Calabar, Nigeria., Methods: A cross sectional observational survey of adolescents aged 13-19 years attending randomly selected secondary schools in Calabar, Nigeria. It involved the use of questionnaires and subsequent whole body examination., Results: A total of 1447 senior secondary school students were examined. Infectious dermatoses, infestations, and papular urticaria (IDIP) were observed in 505 (34.9%) persons, among whom were 269 (53.3%) males, and 236 (46.7%) females (X
2 =34.87, p=<0.001). Fungal dermatoses constituted more than 90% of the diseases, the bulk of which was contributed by pityriasis versicolor [430 (79.6%)]. The six most common dermatoses in descending order of frequencies were Pityriasis versicolor, tinea, papular urticaria, candidiasis, furuncles, and viral warts., Conclusion: A high prevalence of cutaneous infections exists among teenage adolescents in Calabar, Nigeria. Males have a higher predisposition to fungal dermatoses. Control of the predominant cause of cutaneous infections - pityriasis versicolor, will significantly affect the prevalence of infectious dermatoses, and invariably, the burden of skin disorders in adolescents in Calabar, Nigeria., Funding: Self sponsored., Competing Interests: Conflict of interest: None declared, (Copyright © The Author(s).)- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.